PhenoVista Biosciences
PhenoVista Biosciences is dedicated to enabling life scientists to develop cures within months, not years, through advanced high-content imaging and phenotypic assays. They leverage state-of-the-art imaging instrumentation, in-house informatics, and a collaborative approach to deliver high-quality, quantitative biological data for complex biological questions across various disease areas. They offer a wide range of in vitro phenotypic screening and assay services, including custom assay development, high-content imaging, and specialized disease models such as neurodegenerative, fibrosis, and gene therapy applications. Their services are designed to accelerate drug discovery, improve translational relevance, and de-risk R&D efforts.
Industries
Nr. of Employees
small (1-50)
Products
Custom Assay Services
Collaborate with PhenoVista's team to design and execute assays tailored to specific, complex biological questions.
Ready-2-Go Assay Services
Pre-defined, pre-validated in vitro assays designed to deliver actionable data quickly and cost-efficiently.
Cell Imaging & Analysis Services
Provides quantitative data on therapeutic candidates' biological effects through advanced microscopy techniques.
In Vitro Fibrosis Assay Services
Offers insights into anti-fibrotic drug candidates using in vitro assays for various types of fibrosis.
In Vitro Neurobiology Assay Services
Provides insights into CNS-targeting drugs using predictive, physiologically relevant disease models.
Cell Painting Assay Service
An image-based phenotypic profiling method to identify and measure phenotypic differences and mechanisms of action.
Custom Assay Services
Collaborate with PhenoVista's team to design and execute assays tailored to specific, complex biological questions.
Ready-2-Go Assay Services
Pre-defined, pre-validated in vitro assays designed to deliver actionable data quickly and cost-efficiently.
Cell Imaging & Analysis Services
Provides quantitative data on therapeutic candidates' biological effects through advanced microscopy techniques.
In Vitro Fibrosis Assay Services
Offers insights into anti-fibrotic drug candidates using in vitro assays for various types of fibrosis.
In Vitro Neurobiology Assay Services
Provides insights into CNS-targeting drugs using predictive, physiologically relevant disease models.
Cell Painting Assay Service
An image-based phenotypic profiling method to identify and measure phenotypic differences and mechanisms of action.
Services
Collaborative project-based design and execution of bespoke in vitro assays tailored to specific biological questions, including novel model development, custom staining palettes, treatment paradigms, and bespoke readouts.
Standardized, predefined in vitro assay offerings across disease areas that deliver quantitative data using scaled workflows and defined panels; typical turnaround is 6–8 weeks with options for bulk discounts and no minimum orders.
Comparative assessment of AAV transduction and tropism: client-selected human cell types are treated with multiple AAV serotypes alongside the client construct to quantify transduction efficiency and preferential uptake; results can be bundled with cell-health or neurotoxicity readouts.
Accept customer-shipped fixed & stained plates for plate-scanning, multi-channel imaging, quantitative feature extraction, and delivery of analyzed datasets and reports supporting mechanism-of-action, efficacy, and validation studies.
Support screening campaigns that combine automated liquid handling, plate-based imaging, and data analysis to identify and prioritize promising compounds or modalities using phenotypic readouts.
Expert consultation to guide assay design, experimental planning, model selection, endpoint definition, and transition planning from predefined to custom workflows.
Collaborative project-based design and execution of bespoke in vitro assays tailored to specific biological questions, including novel model development, custom staining palettes, treatment paradigms, and bespoke readouts.
Standardized, predefined in vitro assay offerings across disease areas that deliver quantitative data using scaled workflows and defined panels; typical turnaround is 6–8 weeks with options for bulk discounts and no minimum orders.
Comparative assessment of AAV transduction and tropism: client-selected human cell types are treated with multiple AAV serotypes alongside the client construct to quantify transduction efficiency and preferential uptake; results can be bundled with cell-health or neurotoxicity readouts.
Accept customer-shipped fixed & stained plates for plate-scanning, multi-channel imaging, quantitative feature extraction, and delivery of analyzed datasets and reports supporting mechanism-of-action, efficacy, and validation studies.
Support screening campaigns that combine automated liquid handling, plate-based imaging, and data analysis to identify and prioritize promising compounds or modalities using phenotypic readouts.
Expert consultation to guide assay design, experimental planning, model selection, endpoint definition, and transition planning from predefined to custom workflows.
Expertise Areas
- High-content imaging and quantitative image analysis
- Phenotypic assay development and phenotypic profiling
- Human iPSC-derived disease modeling and multi-cell type cultures
- Cell and gene therapy in vitro assay development
Key Technologies
- High-content fluorescence microscopy
- Multiplexed fluorescent staining assays
- iPSC differentiation and scalable iPSC-derived cell panels
- 3D culture systems (spheroids, organoids) and bioprinting
News & Updates
Learn about the basic principles and process of high-content screening with tips on how to design a successful assay.
Learn how expertise in developing complex, in vitro studies can help drive drug discovery forward.
Learn about the basic principles and process of high-content screening with tips on how to design a successful assay.
Learn how expertise in developing complex, in vitro studies can help drive drug discovery forward.